WallStSmart
TGTX

TG Therapeutics Inc

NASDAQ: TGTX · HEALTHCARE · BIOTECHNOLOGY

$33.58
-2.89% today

Updated 2026-04-29

Market cap
$5.36B
P/E ratio
12.12
P/S ratio
8.70x
EPS (TTM)
$2.77
Dividend yield
52W range
$25 – $46
Volume
2.0M

TG Therapeutics Inc (TGTX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-7.75M$-10.23M$-4.44M$-1.05M$-1.97M$-86577.00$-5.19M$-10.82M$-35.06M$-44.69M$-61.59M$-93.76M$-128.93M$-132.81M$-214.51M$-295.63M$-176.17M$-31.41M$-40.52M$-24.77M
Capital expenditures$37052.00$9134.00$8973.00$0.00$2844.00$0.00$1399.00$5681.00$18570.00$42217.00$343985.00$2227.00$90000.00$131000.00$357000.00$401000.00$14000.00$0.00$45000.00$214000.00
Depreciation
Stock-based comp$1.68M$463890.00$353438.00$217479.00$86494.00$3.42M$5.20M$21.11M$15.70M$7.51M$15.95M$12.89M$11.34M$80.29M$61.27M$19.18M$37.93M$42.54M$64.67M
Free cash flow$-7.79M$-10.24M$-4.45M$-1.05M$-1.97M$-86577.00$-5.19M$-10.83M$-35.08M$-44.73M$-61.94M$-93.77M$-129.01M$-132.94M$-214.86M$-296.04M$-176.18M$-31.41M$-40.56M$-24.99M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$9.75M$6.71M$24.03M$15.23M$-652455.00$-30.03M$31.69M$-14.11M$70.69M$440.81M$-254.55M$-196.57M